The startup develops a virtual reality-based device that combines gamified visual therapy with dichoptic exercises to treat amblyopia in children. This wearable medical product allows parents to monitor therapy sessions and track adherence to treatment through engaging gameplay.
Funding
$230K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Amblyopia, or lazy eye, in children is traditionally treated with methods like patching, which can suffer from poor adherence due to being cumbersome and visually unengaging. This can lead to suboptimal outcomes and prolonged treatment duration.
Solution
V-Vision offers a virtual reality (VR)-based device that combines visual therapy with dichoptic exercises to treat amblyopia in children, aiming to improve treatment adherence and outcomes. The system uses engaging gameplay within a VR environment to motivate children to complete their therapy sessions. Parents can monitor therapy sessions and track their child's adherence to the treatment regimen through connected devices that provide data to ophthalmologists. The VR technology allows for remote and personalized visual therapy tailored to the specific needs of each patient, offering various modes of therapy with different games.
Target Audience
The primary target audience includes ophthalmologists and optometrists seeking innovative tools for amblyopia treatment, as well as parents of children with amblyopia looking for engaging and effective therapy options.
Features
- VR-based dichoptic therapy with gamified exercises to stimulate visual processing
- Remote monitoring capabilities for parents and specialists to track treatment adherence and progress
- Personalized therapy programs tailored to individual patient needs
- Multiple therapy modes with a variety of engaging games
- Portable optometry cabinet (Dicopt Pro) offering tests such as campimetry, Hess-Lancaster screen, Worth test, Snellen visual acuity, and Amsler grid
- Screening capabilities for central and peripheral visual fields up to 120º with contrast sensitivity strategies